Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Sumitomo Chemical Set to Manufacture RNA for CRISPR Gene Editing

Filed Under: Industry, Pharma Tagged With: , , , , , ,

Sumitomo Chemical Co. Ltd. (TYO:4005) is set to begin supplying pharmaceutical-grade ribonucleic acid (RNA) for use with CRISPR/Cas9 gene editing…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Sumitomo Chemical Eyes Mass Production of Nucleic Acid Drug Substance for Genome Editing
Sumitomo Chemical Eyes Mass Production of Nucleic Acid Drug…
Sumitomo Chemical Pursues Genome Editing for Agricultural Cultivation
Sumitomo Chemical Pursues Genome Editing for Agricultural…
Japan Makes Push for Domestically Developed Genome Editing Technologies
Japan Makes Push for Domestically Developed Genome Editing…
Major Japanese Chemical Players Advance Further Into Life Sciences Venture Tie-ups
Major Japanese Chemical Players Advance Further Into Life…
Nippon Shokubai Uses Genome Editing for High-Yield Butanol Fermentation
Nippon Shokubai Uses Genome Editing for High-Yield Butanol…
Sumitomo Chemical Adds Two New Catalyst Lines to Serve in PP, PO Licensing
Sumitomo Chemical Adds Two New Catalyst Lines to Serve in…